Washington Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
17,320
+5,410
+45% +$356K 0.73% 25
2026
Q1
$848K Buy
11,910
+390
+3% +$30.8K 0.72% 31
2025
Q4
$945K Buy
11,520
+620
+6% +$48.3K 0.77% 26
2025
Q3
$819K Hold
10,900
0.58% 34
2025
Q2
$807K Buy
10,900
+1,800
+20% +$125K 0.6% 38
2025
Q1
$734K Hold
9,100
0.59% 41
2024
Q4
$711K Sell
9,100
-75
-0.8% -$6.38K 0.56% 39
2024
Q3
$861K Hold
9,175
0.66% 38
2024
Q2
$715K Sell
9,175
-1,800
-16% -$147K 0.6% 43
2024
Q1
$998K Hold
10,975
0.81% 28
2023
Q4
$849K Buy
10,975
+75
+0.7% +$5.25K 0.73% 35
2023
Q3
$742K Buy
10,900
+4,800
+79% +$349K 0.68% 38
2023
Q2
$496K Buy
+6,100
New +$487K 0.42% 78

Other funds holding GEHC

Washington Capital Management's GEHC Position: Q2 2026 in Review

Washington Capital Management increased its GE HealthCare (GEHC) stake by 45% in Q2 2026, buying an estimated $356K and bringing the position to 17,320 shares worth $1.11M. The position accounts for 0.73% of the portfolio, ranked #25.

Washington Capital Management first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Washington Capital Management held 17,320 shares of GE HealthCare worth $1.11M as of Q2 2026.
  • Washington Capital Management bought 5,410 GE HealthCare shares in Q2 2026, an estimated $356K.
  • GE HealthCare made up 0.73% of Washington Capital Management's portfolio in Q2 2026, its #25 holding.
  • Washington Capital Management first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Washington Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.